Cargando…
Anti-Inflammatory and Neuroprotective Mechanisms of GTS-21, an α7 Nicotinic Acetylcholine Receptor Agonist, in Neuroinflammation and Parkinson’s Disease Mouse Models
Neuroinflammation is crucial in the progression of neurodegenerative diseases. Thus, controlling neuroinflammation has been proposed as an important therapeutic strategy for neurodegenerative disease. In the present study, we examined the anti-inflammatory and neuroprotective effects of GTS-21, a se...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026703/ https://www.ncbi.nlm.nih.gov/pubmed/35457238 http://dx.doi.org/10.3390/ijms23084420 |
_version_ | 1784691178900291584 |
---|---|
author | Park, Jung-Eun Leem, Yea-Hyun Park, Jin-Sun Kim, Do-Yeon Kang, Jihee Lee Kim, Hee-Sun |
author_facet | Park, Jung-Eun Leem, Yea-Hyun Park, Jin-Sun Kim, Do-Yeon Kang, Jihee Lee Kim, Hee-Sun |
author_sort | Park, Jung-Eun |
collection | PubMed |
description | Neuroinflammation is crucial in the progression of neurodegenerative diseases. Thus, controlling neuroinflammation has been proposed as an important therapeutic strategy for neurodegenerative disease. In the present study, we examined the anti-inflammatory and neuroprotective effects of GTS-21, a selective α7 nicotinic acetylcholine receptor (α7 nAChR) agonist, in neuroinflammation and Parkinson’s disease (PD) mouse models. GTS-21 inhibited the expression of inducible nitric oxide synthase (iNOS) and proinflammatory cytokines in lipopolysaccharide (LPS)-stimulated BV2 microglial cells and primary microglia. Further research revealed that GTS-21 has anti-inflammatory properties by inhibiting PI3K/Akt, NF-κB, and upregulating AMPK, Nrf2, CREB, and PPARγ signals. The effects of GTS-21 on these pro-/anti-inflammatory signaling molecules were reversed by treatment with an α7 nAChR antagonist, suggesting that the anti-inflammatory effects of GTS-21 are mediated through α7 nAChR activation. The anti-inflammatory and neuroprotective properties of GTS-21 were then confirmed in LPS-induced systemic inflammation and MPTP-induced PD model mice. In LPS-injected mouse brains, GTS-21 reduced microglial activation and production of proinflammatory markers. Furthermore, in the brains of MPTP-injected mice, GTS-21 restored locomotor activity and dopaminergic neuronal cell death while inhibiting microglial activation and pro-inflammatory gene expression. These findings suggest that GTS-21 has therapeutic potential in neuroinflammatory and neurodegenerative diseases such as PD. |
format | Online Article Text |
id | pubmed-9026703 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-90267032022-04-23 Anti-Inflammatory and Neuroprotective Mechanisms of GTS-21, an α7 Nicotinic Acetylcholine Receptor Agonist, in Neuroinflammation and Parkinson’s Disease Mouse Models Park, Jung-Eun Leem, Yea-Hyun Park, Jin-Sun Kim, Do-Yeon Kang, Jihee Lee Kim, Hee-Sun Int J Mol Sci Article Neuroinflammation is crucial in the progression of neurodegenerative diseases. Thus, controlling neuroinflammation has been proposed as an important therapeutic strategy for neurodegenerative disease. In the present study, we examined the anti-inflammatory and neuroprotective effects of GTS-21, a selective α7 nicotinic acetylcholine receptor (α7 nAChR) agonist, in neuroinflammation and Parkinson’s disease (PD) mouse models. GTS-21 inhibited the expression of inducible nitric oxide synthase (iNOS) and proinflammatory cytokines in lipopolysaccharide (LPS)-stimulated BV2 microglial cells and primary microglia. Further research revealed that GTS-21 has anti-inflammatory properties by inhibiting PI3K/Akt, NF-κB, and upregulating AMPK, Nrf2, CREB, and PPARγ signals. The effects of GTS-21 on these pro-/anti-inflammatory signaling molecules were reversed by treatment with an α7 nAChR antagonist, suggesting that the anti-inflammatory effects of GTS-21 are mediated through α7 nAChR activation. The anti-inflammatory and neuroprotective properties of GTS-21 were then confirmed in LPS-induced systemic inflammation and MPTP-induced PD model mice. In LPS-injected mouse brains, GTS-21 reduced microglial activation and production of proinflammatory markers. Furthermore, in the brains of MPTP-injected mice, GTS-21 restored locomotor activity and dopaminergic neuronal cell death while inhibiting microglial activation and pro-inflammatory gene expression. These findings suggest that GTS-21 has therapeutic potential in neuroinflammatory and neurodegenerative diseases such as PD. MDPI 2022-04-16 /pmc/articles/PMC9026703/ /pubmed/35457238 http://dx.doi.org/10.3390/ijms23084420 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Park, Jung-Eun Leem, Yea-Hyun Park, Jin-Sun Kim, Do-Yeon Kang, Jihee Lee Kim, Hee-Sun Anti-Inflammatory and Neuroprotective Mechanisms of GTS-21, an α7 Nicotinic Acetylcholine Receptor Agonist, in Neuroinflammation and Parkinson’s Disease Mouse Models |
title | Anti-Inflammatory and Neuroprotective Mechanisms of GTS-21, an α7 Nicotinic Acetylcholine Receptor Agonist, in Neuroinflammation and Parkinson’s Disease Mouse Models |
title_full | Anti-Inflammatory and Neuroprotective Mechanisms of GTS-21, an α7 Nicotinic Acetylcholine Receptor Agonist, in Neuroinflammation and Parkinson’s Disease Mouse Models |
title_fullStr | Anti-Inflammatory and Neuroprotective Mechanisms of GTS-21, an α7 Nicotinic Acetylcholine Receptor Agonist, in Neuroinflammation and Parkinson’s Disease Mouse Models |
title_full_unstemmed | Anti-Inflammatory and Neuroprotective Mechanisms of GTS-21, an α7 Nicotinic Acetylcholine Receptor Agonist, in Neuroinflammation and Parkinson’s Disease Mouse Models |
title_short | Anti-Inflammatory and Neuroprotective Mechanisms of GTS-21, an α7 Nicotinic Acetylcholine Receptor Agonist, in Neuroinflammation and Parkinson’s Disease Mouse Models |
title_sort | anti-inflammatory and neuroprotective mechanisms of gts-21, an α7 nicotinic acetylcholine receptor agonist, in neuroinflammation and parkinson’s disease mouse models |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026703/ https://www.ncbi.nlm.nih.gov/pubmed/35457238 http://dx.doi.org/10.3390/ijms23084420 |
work_keys_str_mv | AT parkjungeun antiinflammatoryandneuroprotectivemechanismsofgts21ana7nicotinicacetylcholinereceptoragonistinneuroinflammationandparkinsonsdiseasemousemodels AT leemyeahyun antiinflammatoryandneuroprotectivemechanismsofgts21ana7nicotinicacetylcholinereceptoragonistinneuroinflammationandparkinsonsdiseasemousemodels AT parkjinsun antiinflammatoryandneuroprotectivemechanismsofgts21ana7nicotinicacetylcholinereceptoragonistinneuroinflammationandparkinsonsdiseasemousemodels AT kimdoyeon antiinflammatoryandneuroprotectivemechanismsofgts21ana7nicotinicacetylcholinereceptoragonistinneuroinflammationandparkinsonsdiseasemousemodels AT kangjiheelee antiinflammatoryandneuroprotectivemechanismsofgts21ana7nicotinicacetylcholinereceptoragonistinneuroinflammationandparkinsonsdiseasemousemodels AT kimheesun antiinflammatoryandneuroprotectivemechanismsofgts21ana7nicotinicacetylcholinereceptoragonistinneuroinflammationandparkinsonsdiseasemousemodels |